本文選題：2型糖尿病 + 飲食治療��； 參考：《成都中醫(yī)藥大學(xué)》2015年碩士論文

【摘要】：研究目的1. 探討多元化量化便捷食譜對2型糖尿病患者疾病控制指標(biāo)的影響。2. 探討多元化量化便捷食譜對2型糖尿病患者負(fù)性情緒(焦慮、抑郁)的影響。3. 探討多元化量化便捷食譜對2型糖尿病患者自我效能水平的影響。4. 探討多元化量化便捷食譜對2型糖尿病患者生存質(zhì)量的影響。5. 探討多元化量化便捷食譜對2型糖尿病患者依從性的影響。研究方法1. 將2014年3月至2014年8月在成都中醫(yī)藥大學(xué)附屬醫(yī)院糖尿病門診符合納入標(biāo)準(zhǔn)的103例2型糖尿病患者,并采用隨機(jī)對照方法將納入的研究對象分為試驗(yàn)組50例和對照組53例。2. 干預(yù)方法：在糖尿病常規(guī)治療護(hù)理的基礎(chǔ)上,對照組采用常規(guī)糖尿病飲食方案,試驗(yàn)組采用多元化量化便捷食譜方案,分別于干預(yù)前、干預(yù)3個(gè)月后采集患者的疾病控制指標(biāo),以評價(jià)其臨床療效；采用自我效能量表(DSES)對患者的自我效能感進(jìn)行評價(jià)；采用漢密爾頓焦慮量表(HAMA)和漢密爾頓抑郁量表(HAMD)評價(jià)患者的負(fù)性情緒(焦慮、抑郁)；采用2型糖尿病生活質(zhì)量評定量表(DMQLS)修訂版對患者的生存質(zhì)量情況進(jìn)行評估；采用糖尿病飲食依從性調(diào)查表評價(jià)患者對飲食方案的依從性。3. 數(shù)據(jù)采集：(1)一般資料：姓名、年齡、性別、婚姻狀況、職業(yè)、文化程度、病程、煙酒史、家族史、伴隨疾病等；(2)療效性指標(biāo)：疾病控制指標(biāo)(BMI、 FPG、2hPBG、HbAlc、HDL-C、LDL-C、TC、TG、SBP、DBP)評價(jià)臨床療效；DSES、HAMA、HAMD、DMQLS評分；(3)依從性：患者依從性評分,用以評價(jià)患者的遵醫(yī)行為。資料均由經(jīng)過培訓(xùn)的研究組成員進(jìn)行收集,干預(yù)前收集以上全部資料,干預(yù)3個(gè)月后收集療效性指標(biāo)及依從性評分。4. 統(tǒng)計(jì)處理：數(shù)據(jù)采用SPSS17.0軟件進(jìn)行數(shù)據(jù)統(tǒng)計(jì)分析。研究結(jié)果1.基線數(shù)據(jù)：干預(yù)前兩組在病例脫失情況、年齡、性別、職業(yè)、婚姻狀況、文化程度、病程、伴隨疾病等方面,差異均無統(tǒng)計(jì)學(xué)意義(P0.05),疾病控制指標(biāo)、DMQLS評分、DSES評分、HAMA評分、HAMD評分、依從性評分的比較,差異均無統(tǒng)計(jì)學(xué)意義(P0.05),具有可比性。2.疾病控制指標(biāo)：組間比較顯示：試驗(yàn)組干預(yù)后HDL-C高于對照組,BMI、 FPG、2hPBG、HbA1c、LDL-C、TC、TG、SBP、DBP等指標(biāo)均低于對照組,差異有統(tǒng)計(jì)學(xué)意義(P0.05)；組內(nèi)比較顯示：兩組干預(yù)后BMI、FPG、2hPBG、 HbA1c、LDL-C、TC、TG、SBP、DBP均低于干預(yù)前,HDL-C均高于干預(yù)前,差異有統(tǒng)計(jì)學(xué)意義(P0.05)。3. DSES評分：組間比較顯示：干預(yù)后試驗(yàn)組DSES得分高于對照組,差異有統(tǒng)計(jì)學(xué)意義(P0.05)；組內(nèi)比較顯示：兩組干預(yù)后DSES評分均高于干預(yù)前,差異有統(tǒng)計(jì)學(xué)意義(P0.05)。4. HAMA、HAMD評分：組間比較顯示：試驗(yàn)組干預(yù)后HAMA、HAMD評分均低于對照組,差異有統(tǒng)計(jì)學(xué)意義(P0.05)；組內(nèi)比較顯示：兩組干預(yù)后HAMA、HAMD評分均低于干預(yù)前,差異有統(tǒng)計(jì)學(xué)意義(P0.05)。5. DMQLS評分：組間比較顯示：干預(yù)后試驗(yàn)組各維度得分均低于對照組,差異均有統(tǒng)計(jì)學(xué)意義(P0.05)；組內(nèi)比較顯示：兩組干預(yù)后DMQLS各維度得分均低于干預(yù)前,差異有統(tǒng)計(jì)學(xué)意義(P0.05)。6.依從性評分：組間比較顯示：干預(yù)后試驗(yàn)組依從性評分均高于對照組,差異有統(tǒng)計(jì)學(xué)意義(P0.05)；組內(nèi)比較顯示：兩組患者依從性評分干預(yù)后均高于干預(yù)前,差異有統(tǒng)計(jì)學(xué)意義(P0.05)。結(jié)論1.多元化量化便捷食譜有助于改善患者血糖、降低血脂、控制血壓,其效果優(yōu)于常規(guī)糖尿病飲食方案組。2. 多元化量化便捷食譜有助于改善患者負(fù)性情緒(焦慮、抑郁),其效果優(yōu)于常規(guī)糖尿病飲食方案組。3.多元化量化便捷食譜有助于提高患者自我效能水平,其效果優(yōu)于常規(guī)糖尿病飲食方案組。4.多元化量化便捷食譜有助于提高2型糖尿病患者的生存質(zhì)量,其效果優(yōu)于常規(guī)糖尿病飲食方案組。5. 多元化量化便捷食譜有助于提高患者的飲食依從性,其效果優(yōu)于常規(guī)糖尿病飲食方案組。
[Abstract]:Objective 1. to explore the influence of multiple quantified and convenient diet on the disease control index of type 2 diabetes patients.2. explore the effect of multiple quantified and convenient diet on negative emotion (anxiety, depression) in type 2 diabetes patients.3. discussion on the effect of diversification and convenience diet on the self-efficacy level of type 2 diabetes patients.4. exploration of diversification The impact of quantified and convenient diet on the quality of life in type 2 diabetes patients.5. explored the effect of a diversified and quantified convenience diet on the compliance of type 2 diabetic patients. Method 1. from March 2014 to August 2014 in the diabetes clinic of the Affiliated Hospital of Chengdu University of Traditional Chinese Medicine, 103 patients with type 2 diabetes were conformed to the inclusion criteria and were randomly selected. The subjects included in the study were divided into 50 cases in the experimental group and 53 cases of the control group with.2. intervention: on the basis of the routine treatment of diabetes, the control group adopted the routine diabetes diet scheme, and the experimental group adopted a diversified and convenient diet scheme. Before the intervention, the patient's disease control index was collected 3 months after the intervention, so as to evaluate the patient's disease control index. The clinical efficacy was evaluated; self efficacy scale (DSES) was used to evaluate the patient's self-efficacy; the Hamilton Anxiety Scale (HAMA) and the Hamilton Depression Scale (HAMD) were used to evaluate the negative emotion (anxiety, depression) of the patients; the quality of life of the patients was revised by the revised version 2 diabetes life quality assessment scale (DMQLS). .3. data collection was assessed by the diabetes diet compliance questionnaire: (1) general information: name, age, sex, marital status, occupation, education, course of illness, history of tobacco and alcohol, family history, disease and so on; (2) therapeutic index: disease control index (BMI, FPG, 2hPBG, HbAlc, HDL-C, LDL-C,) TC, TG, SBP, DBP) evaluation of clinical efficacy; DSES, HAMA, HAMD, DMQLS score; (3) compliance: compliance score of patients to evaluate patients' compliance behavior. Data were collected by trained members of the study group, before intervention, all the above data were collected, and 3 months after intervention, the curative effect index and compliance score were collected. The data were analyzed by SPSS17.0 software. Results 1. baseline data: there were no significant differences between the two groups before intervention in cases of loss of cases, age, sex, occupation, marital status, educational level, disease course, and disease, such as disease control index, DMQLS score, DSES score, HAMA score, HAMD score, compliance. There was no statistically significant difference in sex score (P0.05), and there was a comparable control index of.2. disease: the comparison between groups showed that the HDL-C of the test group was higher than the control group, BMI, FPG, 2hPBG, HbA1c, LDL-C, TC, TG, SBP, DBP and other indexes were lower than those in the control group. 2hPBG, HbA1c, LDL-C, TC, TG, SBP, DBP were all lower than before the intervention, HDL-C was higher than before the intervention, the difference was statistically significant (P0.05).3. DSES score: the comparison between groups showed that the score of DSES scores in the test group was higher than that of the control group, and the difference was statistically significant. The comparison between the two groups showed that the scores of the two groups were higher than those before the intervention, and the difference was unified before the intervention. The study significance (P0.05).4. HAMA, HAMD score: the group comparison showed that the test group was HAMA, the HAMD score was lower than the control group, the difference was statistically significant (P0.05); the group comparison showed that the two groups of dry prognosis HAMA, the HAMD score was lower than before the intervention, the difference was statistically significant (P0.05).5. DMQLS score: the comparison between groups showed: dry prognosis The scores of all dimensions in the test group were lower than those in the control group (P0.05). In the group comparison, the scores of each dimension of DMQLS in the two groups were lower than that before the intervention, and the difference was statistically significant (P0.05).6. compliance score: the comparison between groups showed that the compliance score of the test group was higher than that of the control group, the difference was statistically significant Significance (P0.05); the group comparison showed that the compliance scores of the two groups were all higher than those before the intervention, and the difference was statistically significant (P0.05). Conclusion the multiplex quantitative and convenient diet helps to improve the blood sugar, reduce blood lipid and control the blood pressure. The effect is better than that of the routine glycuria diet group.2. multiplex quantitative convenience diet. The improvement of negative emotion (anxiety, depression) in patients is better than that of the conventional diabetes diet group.3. multiplex convenience diet helps to improve the patient's self-efficacy level. The effect is better than the conventional diabetes diet group.4. multiplex and quantified convenience diet helps to improve the quality of life of patients with type 2 diabetes, and the effect is better than that of the regular diabetes diet group. The.5. multivariate quantitative convenience diet helps improve the dietary compliance of patients. The effect is better than that of the conventional diabetic diet group.
【學(xué)位授予單位】：成都中醫(yī)藥大學(xué)
【學(xué)位級別】：碩士
【學(xué)位授予年份】：2015
【分類號(hào)】：R587.1

【相似文獻(xiàn)】

相關(guān)期刊論文 前10條

1 黃列軍,曹莜芬;糖尿病的主要危害是什么?[J];中國臨床醫(yī)生;2001年01期

2 梅晰凡,王偉;糖尿病足40例療效觀察[J];中國煤炭工業(yè)醫(yī)學(xué)雜志;2001年04期

3 胡懷東,王玉君,龐久高;2型糖尿病患者尿Ⅳ型膠原與糖尿病腎病關(guān)系的研究[J];重慶醫(yī)科大學(xué)學(xué)報(bào);2001年01期

4 盧盛明,戴林,李愛萍;1例糖尿病并發(fā)嚴(yán)重多臟器功能障礙綜合征患者治愈分析[J];中國危重病急救醫(yī)學(xué);2001年09期

5 姜醒,苑光軍,馬麗紅;糖尿病的中醫(yī)藥治療近況[J];中醫(yī)藥信息;2001年05期

6 孫德勝,肖螢;超聲評價(jià)糖尿病腎病[J];中國醫(yī)學(xué)影像技術(shù);2001年01期

7 馬為,郭泉瀅,唐桂軍;以糖腎安為主配合西藥治療糖尿病腎病60例[J];中醫(yī)研究;2001年04期

8 翁小剛;中藥治療3例糖尿病腎病[J];國外醫(yī)學(xué)(中醫(yī)中藥分冊);2001年06期

9 周逸丹;;糖尿病飲食治療現(xiàn)狀[J];國外醫(yī)學(xué)(老年醫(yī)學(xué)分冊);2001年02期

10 滕萬同,楊莉;糖尿病性腹瀉42例治療體會(huì)[J];山東醫(yī)藥;2002年16期

相關(guān)會(huì)議論文 前10條

1 沙洪;肖誠;趙婷婷;郭景珍;黃小潔;王萍;李平;;糖尿病腎病的健康教育[A];中華中醫(yī)藥學(xué)會(huì)第二十一屆全國中醫(yī)腎病學(xué)術(shù)會(huì)議論文匯編（下）[C];2008年

2 楊麗平;李平;;糖尿病腎病合并貧血的相關(guān)發(fā)病機(jī)制[A];中華中醫(yī)藥學(xué)會(huì)第二十一屆全國中醫(yī)腎病學(xué)術(shù)會(huì)議論文匯編（下）[C];2008年

3 周海鷗;王黎芳;楊佳琦;錢大昕;陳士華;;社區(qū)糖尿病病人現(xiàn)狀分析與對策[A];浙江省醫(yī)學(xué)會(huì)醫(yī)學(xué)微生物與免疫學(xué)及醫(yī)學(xué)病毒學(xué)學(xué)術(shù)年會(huì)論文匯編[C];2009年

4 葛菲菲;;糖尿病腎病早期診療進(jìn)展[A];第10屆全國中西醫(yī)結(jié)合腎臟病學(xué)術(shù)會(huì)議論文匯編[C];2009年

5 李桂芝;于道蘭;;糖尿病腎病的飲食調(diào)理[A];中華護(hù)理學(xué)會(huì)全國第6屆重癥監(jiān)護(hù)護(hù)理學(xué)術(shù)交流暨專題講座會(huì)議論文匯編[C];2009年

6 金礫;;淺談糖尿病的護(hù)理[A];第十四次全國中西醫(yī)結(jié)合瘍科學(xué)術(shù)交流會(huì)論文匯編[C];2009年

7 奚九一;;糖尿病足有二種壞死很難分辨,奚氏中醫(yī)辨證可區(qū)別[A];中華中醫(yī)藥學(xué)會(huì)周圍血管病分會(huì)2010年學(xué)術(shù)大會(huì)論文集[C];2010年

8 高繼寧;趙怡蕊;李躍進(jìn);;糖尿病腎病的中西醫(yī)結(jié)合治療新進(jìn)展[A];第十一屆全國中西醫(yī)結(jié)合腎臟病學(xué)術(shù)會(huì)議論文匯編[C];2010年

9 蘆文娟;方敬愛;孫艷艷;張曉東;劉文媛;常沁濤;王蕊花;王月香;李慧;劉婷;;抗壞血酸與糖尿病腎病[A];第十一屆全國中西醫(yī)結(jié)合腎臟病學(xué)術(shù)會(huì)議論文匯編[C];2010年

10 簡桂花;盛曉華;汪年松;;中西醫(yī)結(jié)合治療糖尿病腎病療效觀察[A];第十一屆全國中西醫(yī)結(jié)合腎臟病學(xué)術(shù)會(huì)議論文匯編[C];2010年

相關(guān)重要報(bào)紙文章 前10條

1 馬明愈;現(xiàn)代生活方式導(dǎo)致 糖尿病發(fā)病率迅速上升[N];中國婦女報(bào);2005年

2 主持人 向紅丁博士;糖尿病腎病須早防早治[N];人民政協(xié)報(bào);2002年

3 華悅;預(yù)防糖尿病，從減肥開始[N];上海中醫(yī)藥報(bào);2004年

4 劉冬梅;肥胖糖尿病第一誘因[N];天津日報(bào);2004年

5 李學(xué)燕;中藥輔助治糖尿病腎病[N];健康時(shí)報(bào);2007年

6 李旭紅;中醫(yī)幫您遠(yuǎn)離糖尿病[N];市場報(bào);2007年

7 呂洋;糖尿病患者警惕血管病變[N];衛(wèi)生與生活報(bào);2007年

8 記者　崔昕;中藥早期防治糖尿病腎病取得突破性進(jìn)展[N];中國醫(yī)藥報(bào);2006年

9 崔昕;《糖尿病中醫(yī)防治指南》發(fā)布[N];中國醫(yī)藥報(bào);2007年

10 記者 周穎邋高新軍;防治糖尿病首部中醫(yī)指南發(fā)布[N];中國中醫(yī)藥報(bào);2007年

相關(guān)碩士學(xué)位論文 前10條

1 張雙;糖尿病伴發(fā)貧血的影響因素分析[D];浙江大學(xué);2009年

2 李燕玲;雙重糖尿病臨床特征的探討[D];中南大學(xué);2009年

3 孫永勝;2型糖尿病腎病臨床調(diào)查分析[D];遵義醫(yī)學(xué)院;2009年

4 吳楠;2型糖尿病住院患者慢性腎臟病診斷方法初探[D];復(fù)旦大學(xué);2010年

5 蘇麗麗;尿液的表面增強(qiáng)拉曼光譜檢測用于糖尿病的研究[D];大連理工大學(xué);2011年

6 肖憬;2型糖尿病腎病患者白介素-8、白介素-10的變化及臨床意義[D];蘭州大學(xué);2011年

7 黎雅清;2型糖尿病患者心率變異度與糖尿病腎病的關(guān)系[D];暨南大學(xué);2005年

8 卜彥屏;糖尿病足危險(xiǎn)因素探討[D];天津醫(yī)科大學(xué);2002年

9 陳寬林;血清轉(zhuǎn)化生長因子β_1與2型糖尿病腎病相關(guān)性臨床研究[D];福建醫(yī)科大學(xué);2002年

10 馬文革;社區(qū)2型糖尿病患者治療行為調(diào)查及健康教育干預(yù)效果研究[D];安徽醫(yī)科大學(xué);2004年

，

本文編號(hào)：2071056